Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Volume
1.1.2. Type
1.1.3. Material
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Volume outlook
2.2.2. Type outlook
2.2.3. Material outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. High Flow Needle Sets Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for minimally invasive procedures
3.2.1.2. Rising prevalence of chronic disease
3.2.1.3. Rising aging population
3.2.1.4. Increasing demand for high flow needle sets in home care settings
3.2.2. Market restraint analysis
3.2.2.1. Cost constraints and healthcare budgets
3.2.2.2. Limited adoption in developing regions
3.3. High Flow Needle Sets Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. High Flow Needle Sets Market: Volume Estimates & Trend Analysis
4.1. Volume Market Share, 2018 & 2030
4.2. Segment Dashboard
4.3. Global High Flow Needle Sets Market by Volume Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
4.4.1. Less than 10ml
4.4.1.1. Less than 10ml market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. 10-100ml
4.4.2.1. 10-100ml market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. More than 100ml
4.4.3.1. More than 100ml market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. High Flow Needle Sets Market: Type Estimates & Trend Analysis
5.1. Type Market Share, 2018 & 2030
5.2. Segment Dashboard
5.3. Global High Flow Needle Sets Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
5.4.1. 26 Gauge High Flow Needle Sets
5.4.1.1. 26-gauge high flow needle sets market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. 24 Gauge High Flow Needle Sets
5.4.2.1. 24-gauge high flow needle sets market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. 2Others
5.4.3.1. Others high flow needle sets market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. High Flow Needle Sets Market: Material Estimates & Trend Analysis
6.1. Material Market Share, 2018 & 2030
6.2. Segment Dashboard
6.3. Global High Flow Needle Sets Market by Material Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
6.4.1. Stainless Steel
6.4.1.1. Stainless steel market estimates and forecast 2018 to 2030 (USD Million)
6.4.2. Polycarbonate
6.4.2.1. Polycarbonate market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. High Flow Needle Sets Market: End-use Estimates & Trend Analysis
7.1. End-use Market Share, 2018 & 2030
7.2. Segment Dashboard
7.3. Global High Flow Needle Sets Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
7.4.1. Hospitals
7.4.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
7.4.2. Ambulatory Surgical Centers
7.4.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
7.4.3. Diagnostic Centers
7.4.3.1. Diagnostic centers market estimates and forecast 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. High Flow Needle Sets Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2018 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2024 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. Reimbursement scenario
8.5.1.5. U.S. market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. Canada market estimates and forecast, 2018 – 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement scenario
8.6.1.5. UK market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Germany market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. France market estimates and forecast, 2018 – 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Reimbursement scenario
8.6.4.5. Italy market estimates and forecast, 2018 – 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Reimbursement scenario
8.6.5.5. Spain market estimates and forecast, 2018 – 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. Reimbursement scenario
8.6.6.5. Norway market estimates and forecast, 2018 – 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Competitive scenario
8.6.7.3. Regulatory framework
8.6.7.4. Reimbursement scenario
8.6.7.5. Sweden market estimates and forecast, 2018 – 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Competitive scenario
8.6.8.3. Regulatory framework
8.6.8.4. Reimbursement scenario
8.6.8.5. Denmark market estimates and forecast, 2018 – 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement scenario
8.7.1.5. Japan market estimates and forecast, 2018 – 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. China market estimates and forecast, 2018 – 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Reimbursement scenario
8.7.3.5. India market estimates and forecast, 2018 – 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Regulatory framework
8.7.4.4. Reimbursement scenario
8.7.4.5. Australia market estimates and forecast, 2018 – 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. Regulatory framework
8.7.5.4. Reimbursement scenario
8.7.5.5. South Korea market estimates and forecast, 2018 – 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Competitive scenario
8.7.6.3. Regulatory framework
8.7.6.4. Reimbursement scenario
8.7.6.5. Thailand market estimates and forecast, 2018 – 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. Reimbursement scenario
8.8.1.5. Brazil market estimates and forecast, 2018 – 2030 (USD Million)
8.8.2. Mexico
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Reimbursement scenario
8.8.2.5. Mexico market estimates and forecast, 2018 – 2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. Reimbursement scenario
8.8.3.5. Argentina market estimates and forecast, 2018 – 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Competitive scenario
8.9.1.3. Regulatory framework
8.9.1.4. Reimbursement scenario
8.9.1.5. South Africa market estimates and forecast, 2018 – 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Competitive scenario
8.9.2.3. Regulatory framework
8.9.2.4. Reimbursement scenario
8.9.2.5. Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Competitive scenario
8.9.3.3. Regulatory framework
8.9.3.4. Reimbursement scenario
8.9.3.5. UAE market estimates and forecast, 2018 – 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Competitive scenario
8.9.4.3. Regulatory framework
8.9.4.4. Reimbursement scenario
8.9.4.5. Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. AmDel
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. B. Braun Medical Inc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Concordance Healthcare Solutions
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. GEORGE PHILIPS MEDICAL ENGINEERING Pvt. Ltd
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. KORU Medical Systems
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Medline Industries, Inc.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Norfolk Medical
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Integrated Medical System (IMS)
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Thermo Fisher Scientific.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. MEDIWIDE SDN BHD
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.3.14. AngioDynamics, Inc.
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Product benchmarking
9.3.14.4. Strategic initiatives
9.3.15. Jordan Medical
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Product benchmarking
9.3.15.4. Strategic initiatives
9.3.16. McKesson Corporation
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Product benchmarking
9.3.16.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/